Kewalramani Reshma bought VRTX
February 6, 2024 · Form 4 insider transaction
Kewalramani Reshma bought 14,516 shares of Vertex Pharmaceuticals Incorporated at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
14,516
Price
$0.00
Total value
N/A
InsiderKewalramani Reshma
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateFebruary 6, 2024
Filing dateFebruary 8, 2024
Shares owned after123,227
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents earned performance shares with respect to a performance stock unit award granted on 02/03/2021 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/06/2024 and the shares will vest on 02/20/2024.